Stock Updates

How has GlaxoSmithKline plc:(NYSE:GSK) performed recently?

GlaxoSmithKline plc (NYSE: GSK) is a large market cap stock with a market cap of 107299.97. It is in the Drug Manufacturers – Major industry and sector Healthcare, with a current P/E of 3155, a forward P/E of 15.92 and EPS of 0.01. At a stock price of 44.45 (0.63%) it has a dividend yield of 4.98%.

EPS growth for the last five years have been 40.20%, more recently this last year it has grown by 204.10%. The next year growth is going to be about 6.61% and more long-term 10.00% after five years. EPS growth quarter over quarter is -392.80%. Sales growth for the past five years have been -3.40% and sales growth quarter over quarter is 10.90%.

For performance, GlaxoSmithKline plc the past week has seen a gain of -0.49%. For the last month performance for GlaxoSmithKline plc is 1.83%. While the last quarter is 6.59% and half year, 17.45%. Finally for the year, performance is 7.91%.

The 52-week high for GlaxoSmithKline plc, is at -1.38%, and for the 52-week low it comes to a value of 27.98%. The 20-day simple moving average is 4.11% and 10.68% for the 200-day simple moving average.

Volatility for the week is at 0.85%, and for the month it is 0.91%. GlaxoSmithKline plc, has a target price of 48.67.

In terms of debt, long term debt/equity is 26.3, and for total debt/equity GlaxoSmithKline plc has 34.11. The gross margin is 66.60%, while operating margin is 5.30%, the profit margin is 0.10%. The current ratio is 0.9 and the quick ratio is 0.6.

Insider ownership is at 0.20%, with instituitional ownership at 8.80%. GlaxoSmithKline plc has a payout ratio of *TBA. With the total shares outstanding coming to 2429.25. The shares float is 2416.46, with the float short at 0.26%, with short ratio coming to 1.87.

In terms of returns, the return on assets see GlaxoSmithKline plc, get 0.10%, with its returns on investment at 41.40%. Return on equity is 0.90%. So will the investors see the target price of 48.67, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Stephen Butters

Leave a Comment